Header Logo

Connection

GEORGE NOON to Heart Failure

Back to Details
This is a "connection" page, showing publications GEORGE NOON has written about Heart Failure.
GEORGE NOON
Connection Strength
1.623
Heart Failure
  1. Heterotopic heart transplantation: the United States experience. Heart Surg Forum. 2014 Jun; 17(3):E132-40.
    View in: PubMed
    Score: 0.177
  2. Current status of the MicroMed DeBakey Noon Ventricular Assist Device. Tex Heart Inst J. 2010; 37(6):652-3.
    View in: PubMed
    Score: 0.131
  3. Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. J Heart Lung Transplant. 2010 Feb; 29(2):195-200.
    View in: PubMed
    Score: 0.128
  4. What price support? Ventricular assist device induced systemic response. ASAIO J. 2003 Sep-Oct; 49(5):518-26.
    View in: PubMed
    Score: 0.084
  5. New surgical therapies for heart failure. Curr Opin Cardiol. 2003 May; 18(3):194-8.
    View in: PubMed
    Score: 0.082
  6. End-stage cardiac failure in a morbidly obese patient treated by biliopancreatic diversion and cardiac transplantation. Obes Surg. 2002 Jun; 12(3):416-8.
    View in: PubMed
    Score: 0.077
  7. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg. 2001 Mar; 71(3 Suppl):S133-8; discussion S144-6.
    View in: PubMed
    Score: 0.071
  8. Turbine blood pumps. Adv Card Surg. 2001; 13:169-91.
    View in: PubMed
    Score: 0.070
  9. Development and clinical application of the MicroMed DeBakey VAD. Curr Opin Cardiol. 2000 May; 15(3):166-71.
    View in: PubMed
    Score: 0.067
  10. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. Circulation. 1999 Sep 14; 100(11):1189-93.
    View in: PubMed
    Score: 0.064
  11. Acute and temporary ventricular support with BioMedicus centrifugal pump. Ann Thorac Surg. 1999 Aug; 68(2):650-4.
    View in: PubMed
    Score: 0.063
  12. Circulatory support 1991. The Second International Conference on Circulatory Support Devices for Severe Cardiac Failure. Management of secondary organ dysfunction. Ann Thorac Surg. 1993 Jan; 55(1):222-6.
    View in: PubMed
    Score: 0.040
  13. Surgical therapy of end-stage heart failure: understanding cell-mediated mechanisms interacting with myocardial damage. Int J Artif Organs. 2011 Jul; 34(7):529-45.
    View in: PubMed
    Score: 0.036
  14. Left ventricular function in patients with centrifugal left ventricular assist device. ASAIO Trans. 1989 Jul-Sep; 35(3):544-7.
    View in: PubMed
    Score: 0.032
  15. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure. J Heart Lung Transplant. 2008 Jul; 27(7):701-9.
    View in: PubMed
    Score: 0.029
  16. Pleural effusion after ventricular assist device placement: prevalence and pleural fluid characteristics. Chest. 2008 Aug; 134(2):382-386.
    View in: PubMed
    Score: 0.029
  17. TandemHeart insertion via a femoral arterial GORE-TEX graft conduit in a high-risk patient. Tex Heart Inst J. 2008; 35(4):462-5.
    View in: PubMed
    Score: 0.028
  18. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling. J Heart Lung Transplant. 2007 Jan; 26(1):34-40.
    View in: PubMed
    Score: 0.026
  19. Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium. Am J Cardiol. 2006 Jun 01; 97(11):1626-9.
    View in: PubMed
    Score: 0.025
  20. Early mobilization of LVAD recipients who require prolonged mechanical ventilation. Tex Heart Inst J. 2006; 33(2):130-3.
    View in: PubMed
    Score: 0.025
  21. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant. 2005 May; 24(5):566-75.
    View in: PubMed
    Score: 0.024
  22. Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. J Am Coll Cardiol. 2005 Mar 15; 45(6):962-3.
    View in: PubMed
    Score: 0.023
  23. Placement of a left ventricular assist device in a patient with dextrocardia. J Heart Lung Transplant. 2005 Mar; 24(3):338-9.
    View in: PubMed
    Score: 0.023
  24. Role of mast cells and their mediators in failing myocardium under mechanical ventricular support. J Heart Lung Transplant. 2004 Jun; 23(6):709-15.
    View in: PubMed
    Score: 0.022
  25. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol. 2004 Mar 03; 43(5):811-7.
    View in: PubMed
    Score: 0.022
  26. Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant. 2004 Jan; 23(1):36-42.
    View in: PubMed
    Score: 0.022
  27. End-stage heart failure with multiple intracardiac thrombi: a rescue strategy. Tex Heart Inst J. 2004; 31(4):404-8.
    View in: PubMed
    Score: 0.022
  28. Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial. Curr Opin Cardiol. 2003 Nov; 18(6):454-7.
    View in: PubMed
    Score: 0.021
  29. Patient selection for assist devices: bridge to transplant. Curr Opin Cardiol. 2003 Mar; 18(2):141-6.
    View in: PubMed
    Score: 0.020
  30. New strategies for the management of acute decompensated heart failure. Curr Opin Cardiol. 2001 May; 16(3):164-73.
    View in: PubMed
    Score: 0.018
  31. Transcranial detection of microembolic signals in patients with a novel nonpulsatile implantable LVAD. ASAIO J. 2001 May-Jun; 47(3):249-53.
    View in: PubMed
    Score: 0.018
  32. Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. ASAIO J. 2001 May-Jun; 47(3):272-4.
    View in: PubMed
    Score: 0.018
  33. Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist device. Circulation. 2000 Nov 07; 102(19 Suppl 3):III183-7.
    View in: PubMed
    Score: 0.017
  34. Cardiac transplantation: the final therapeutic option for the treatment of heart failure. Curr Opin Cardiol. 2000 May; 15(3):178-82.
    View in: PubMed
    Score: 0.017
  35. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation. 2000 Feb 01; 101(4):356-9.
    View in: PubMed
    Score: 0.016
  36. Anatomic constraints for a total artificial heart in orthotopic heart transplant recipients. J Heart Lung Transplant. 1994 Mar-Apr; 13(2):250-62.
    View in: PubMed
    Score: 0.011
  37. Quantitative changes in mast cell populations after left ventricular assist device implantation. ASAIO J. 2005 May-Jun; 51(3):275-80.
    View in: PubMed
    Score: 0.006
  38. The rotary blood pump: lessons learned and future directions. Artif Organs. 2004 Oct; 28(10):865-8.
    View in: PubMed
    Score: 0.006
  39. [The DeBakey VAD axial flow pump: first clinical experience with a new generation of implantable, nonpulsatile blood pumps for long-term support prior to transplantation]. Wien Klin Wochenschr. 1999 Sep 03; 111(16):629-35.
    View in: PubMed
    Score: 0.004
  40. A pivot bearing-supported centrifugal pump for a long-term assist heart. Int J Artif Organs. 1997 Apr; 20(4):222-8.
    View in: PubMed
    Score: 0.003
  41. Heterotopic heart transplantation and native heart ventricular arrhythmias. Ann Thorac Surg. 1991 Jun; 51(6):987-91.
    View in: PubMed
    Score: 0.002
  42. Heart transplantation: no longer an experiment. Tex Med. 1988 Dec; 84(12):48-55.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.